Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Closes Euroscreen and Evotec Acquisitions

NEW YORK (GenomeWeb News) — PerkinElmer has closed its acquisition of Euroscreen Products and Evotec Technologies, the company said Wednesday.
 
PerkinElmer paid $30.5 million for Evotec, a German company that makes and sells tools for high-throughput and high-content cell and biochemical screening.
 
The company did not disclose the purchase price for the Belgium-based Euroscreen, which provides GPCR membranes, cell lines, and an aequorin-based cellular assay to drug makers.
 
PerkinElmer said ongoing revenue for the combined companies in 2006 was around $25 million, and said the acquisitions should be “neutral to slightly accretive” for its 2007 earnings per share.
 
On Jan. 2 PerkinElmer said it bought the thermal-analysis product line from the British company Triton Technologies.
The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.